Atai Beckley N.V
public_traded
Atai Beckley N.V is publicly traded on NASDAQ under ticker ATAI.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.